CEEM Royalty Rates & Deal Terms Survey
CEEM Survey Respondents
Like the Global BioPharma survey, the CEEM survey was also launched in October. Participation included academic institutions (34%), operating companies that ranged from big energy to start-up (39%), lawyers (16%), and other licensing organizations (11%). Deals submitted were primarily from the chemicals and energy industry segments making up approximately 52% and 28%, respectively, of the total responses.
Key CEEM Deal Statistics
Approximately 70% of the deals collected contained flat running royalties and most deals were entered by the licensor. About 75% of the deals were executed during 2008 or 2009 and 80% of the deals came from the chemicals and energy sectors. Of those reported, approximately 40% of the deals estimated peak annual sales of less than $50 million, most deals involved commercialized or soon to be commercialized products/technologies and a majority of the deals were exclusive.
The full survey report, with over 100 pages of analysis and data, is available exclusively to LES (USA & Canada) members. Click here to access the survey.
Click here for an executive summary of the survey, or click here to access the complete results. The full survey is an LES members only resource, so please login for access.